Newsmax files antitrust lawsuit against Fox News, alleging illegal monopoly and exclusionary practices to stifle competition in the right-leaning pay TV news market.
Sanofi's experimental eczema drug amlitelimab falls short of expectations, raising concerns about the company's ability to replace Dupixent's revenue after patent expiry.
St. Louis Fed's Musalem backs current monetary policy ahead of September meeting, citing full employment and inflation slightly above target.
Newsmax files antitrust lawsuit against Fox News, alleging illegal monopoly and exclusionary practices to stifle competition in the right-leaning pay TV news market.
Sanofi's experimental eczema drug amlitelimab falls short of expectations, raising concerns about the company's ability to replace Dupixent's revenue after patent expiry.
St. Louis Fed's Musalem backs current monetary policy ahead of September meeting, citing full employment and inflation slightly above target.